Mineralys Therapeutics, Inc. (MLYS): Weighted Average Diluted Shares

Annual figures by period end, from SEC filings.

67.66M
Year ended 2025-12-31
+135.7%
3-year compound annual growth
2022-12-31: 5.17M2023-12-31: 36.19M2024-12-31: 48.54M2025-12-31: 67.66M67.66M
2022-12-31 Weighted Average Diluted Shares (shares) 2025-12-31
Period endedWeighted Average Diluted SharesChange YoYSource filing
2025-12-3167.66M+39.4%2026-03-12, From 2025-01-01
2024-12-3148.54M+34.1%2026-03-12, From 2024-01-01
2023-12-3136.19M+600.3%2025-02-12, From 2023-01-01
2022-12-315.17Mn/a2024-03-21, From 2022-01-01